Li YM - Search Results

1

Upregulation of IKKalpha/IKKbeta by integrin-linked kinase is required for HER2/neu-induced NF-kappaB antiapoptotic pathway.

Makino K, Day CP, Wang SC, Li YM, Hung MC. Makino K, et al. Among authors: li ym. Oncogene. 2004 May 6;23(21):3883-7. doi: 10.1038/sj.onc.1207485. Oncogene. 2004. PMID: 15021910

2

Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis.

Li YM, Pan Y, Wei Y, Cheng X, Zhou BP, Tan M, Zhou X, Xia W, Hortobagyi GN, Yu D, Hung MC. Li YM, et al. Cancer Cell. 2004 Nov;6(5):459-69. doi: 10.1016/j.ccr.2004.09.027. Cancer Cell. 2004. PMID: 15542430 Free article.

3

A hypoxia-independent hypoxia-inducible factor-1 activation pathway induced by phosphatidylinositol-3 kinase/Akt in HER2 overexpressing cells.

Li YM, Zhou BP, Deng J, Pan Y, Hay N, Hung MC. Li YM, et al. Cancer Res. 2005 Apr 15;65(8):3257-63. doi: 10.1158/0008-5472.CAN-04-1284. Cancer Res. 2005. PMID: 15833858

4

Enhancement of Bik antitumor effect by Bik mutants.

Li YM, Wen Y, Zhou BP, Kuo HP, Ding Q, Hung MC. Li YM, et al. Cancer Res. 2003 Nov 15;63(22):7630-3. Cancer Res. 2003. PMID: 14633680

5

Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition.

Zhou BP, Deng J, Xia W, Xu J, Li YM, Gunduz M, Hung MC. Zhou BP, et al. Among authors: li ym. Nat Cell Biol. 2004 Oct;6(10):931-40. doi: 10.1038/ncb1173. Epub 2004 Sep 26. Nat Cell Biol. 2004. PMID: 15448698

6

beta-catenin interacts with and inhibits NF-kappa B in human colon and breast cancer.

Deng J, Miller SA, Wang HY, Xia W, Wen Y, Zhou BP, Li Y, Lin SY, Hung MC. Deng J, et al. Cancer Cell. 2002 Oct;2(4):323-34. doi: 10.1016/s1535-6108(02)00154-x. Cancer Cell. 2002. PMID: 12398896 Free article.

7

HER-2/Neu signaling and therapeutic approaches in breast cancer.

Zhou BP, Li Y, Hung MC. Zhou BP, et al. Breast Dis. 2002;15:13-24. doi: 10.3233/bd-2002-15103. Breast Dis. 2002. PMID: 15687642

8

Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin.

Ding Q, Xia W, Liu JC, Yang JY, Lee DF, Xia J, Bartholomeusz G, Li Y, Pan Y, Li Z, Bargou RC, Qin J, Lai CC, Tsai FJ, Tsai CH, Hung MC. Ding Q, et al. Mol Cell. 2005 Jul 22;19(2):159-70. doi: 10.1016/j.molcel.2005.06.009. Mol Cell. 2005. PMID: 16039586 Free article.

9

Cancer-specific activation of the survivin promoter and its potential use in gene therapy.

Chen JS, Liu JC, Shen L, Rau KM, Kuo HP, Li YM, Shi D, Lee YC, Chang KJ, Hung MC. Chen JS, et al. Among authors: li ym. Cancer Gene Ther. 2004 Nov;11(11):740-7. doi: 10.1038/sj.cgt.7700752. Cancer Gene Ther. 2004. PMID: 15359286

10

Suppression of pancreatic tumor progression by systemic delivery of a pancreatic-cancer-specific promoter driven Bik mutant.

Li Z, Ding Q, Li Y, Miller SA, Abbruzzese JL, Hung MC. Li Z, et al. Cancer Lett. 2006 May 8;236(1):58-63. doi: 10.1016/j.canlet.2005.05.001. Epub 2005 Jun 13. Cancer Lett. 2006. PMID: 15953675

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,671 results

Search Page

Filters